China COVID-19 diagnostics market is estimated to see a decline in CAGR of 25.1% during the forecast period. China has significant market share in the global COVID-19 diagnostic market owing to the growing number of diagnostic screening in the country coupled with government initiatives for providing rapid screening for COVID-19. For instance, on May 22, 2020, Chinese health authorities in the city of Wuhan claimed that they have tested around 9.8 million people for COVID-19 within 10 days. The government of the Wuhan spent around $126.6 million on this campaign. In the pool testing campaign, the authorities set up at least 231 testing booths in neighborhoods across the city. Moreover, The Chinese National Health Committee's data, which is compiled by the Chinese government confirms, as of June 22, 2020, China had conducted 90.41 million tests across the country.

Visit for Global COVID-19 Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/covid-19-diagnostics-market

China COVID-19 diagnostics market is segmented on the basis of technology type, end-use, sample type, and product type. By end-use, the COVID-19 diagnostic market is divided into laboratories, hospitals, diagnostic centers & clinics, and research institutes. By product type, the market is further segmented into instruments, reagents & kits, and laboratory testing services. By Sample type, the market is divided into oropharyngeal & nasopharyngeal swabs, blood, urine, saliva, and others. By technology type, the market is further segmented into PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test. Among these, the PCR segment has a major share in the COVID-19 diagnostics market. The factor that enhances the PCR test adoption includes a wide availability of tests and generation of the accurate results. However, due to its time consuming and expensive nature, these tests are substituted with other tests such as serology tests.

The companies which are contributing to the growth of the China COVID-19 diagnostics market include BGI Group, Da An Gene Co., Ltd., Maccura Biotechnology Co., Ltd., Sansure Biotech Inc., and Guangzhou Wondfo Biotech Co., Ltd. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. For instance, in February 2020, BGI and Partners, the Mammoth Foundation, and the Shenzhen Foundation for International Exchange and Cooperation, both based in Shenzhen, China announced to donate COVID-19 test kits to Japan.

Research Methodology

The market study of the China COVID-19 diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.

Market Segmentation

• China COVID-19 Diagnostics Market Research and Analysis by Type
• China COVID-19 Diagnostics Market Research and Analysis by Technology Type
• China COVID-19 Diagnostics Market Research and Analysis by Sample Type
• China COVID-19 Diagnostics Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of the China COVID-19 diagnostics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the China COVID-19 diagnostics market.
• Insights about market determinants which are stimulating the China COVID-19 diagnostics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.